R. Correa-Rotter
The Lancet · 2002–2020
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom R. Correa-Rotter trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Eric R. Ziegel (in Artificial Intelligence)
Papers from R. Correa-Rotter's perspective
Ordered by how strongly the researchers R. Correa-Rotter trusts endorse each paper. Same corpus, a different order for every researcher.
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
- Generalized Linear Models
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
- Guidelines for investigating causality of sequence variants in human disease
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. (The Lancet)
- The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
- Genetic Misdiagnoses and the Potential for Health Disparities
- Uric acid and chronic kidney disease: which is chasing which? (Nephrology, Dialysis and Transplantation)
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Their papers
- Dapagliflozin in Patients with Chronic Kidney Disease. (2020) — 3,594 citations
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017) — 787 citations
- Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. (2016) — 702 citations
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. (2013) — 2,001 citations
- Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. (2012) — 879 citations
- Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. (2002) — 988 citations